The Institute of Emerging Diseases and Innovative Therapies is interested in new diseases (infectious or genetic). Its researchers rely on the study of pathogenic processes, including the role of the immune system, in order to develop new vaccine strategies and therapeutic approaches (gene therapy). Its teams can be mobilized by the government in case of an epidemic or other health crisis (prions, influenza, Chikungunya, etc.).
The research Institute of cellular and molecular radiobiology (IRCM) is unique in Europe and has internationally recognized research activities in radiobiology, radiotherapy, genome stability, cancer and tissue regeneration. The creativity and ingenuity of the researchers together with state-of-the-art facilities have positioned IRCM to undertake fundamental research on model organisms, research on human pathologies and their treatments and research associated with industrial development.